Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryDetection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agentThe matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma.Invasion and metastasis of renal cell carcinoma.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue.Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.Chronic Inhalation of E-Cigarette Vapor Containing Nicotine Disrupts Airway Barrier Function and Induces Systemic Inflammation and Multi-Organ Fibrosis in Mice.STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors
P2860
Q27013843-0666D19A-1CB0-45CD-922D-A03922769400Q33609420-5D6E363D-7FBE-45AC-8F96-6B19802AF786Q33641250-5C6347C9-BE11-43CC-BB0F-961E27BA0A20Q33860861-270A7277-FCE8-4647-805D-755FCC437CB9Q37111026-687F9C53-1B41-407E-980F-8E46DFFAC3F4Q38161397-F3D5BDA5-C8B1-48F6-81D8-E7076327D677Q38224605-A5B8920F-E6C9-455A-AB9E-6CB4372E3CF3Q42053210-25116E08-D40E-41E9-8300-7AF809A996F0Q46538131-934A1124-D7D7-4957-985A-00FE1520AE31Q49559280-AAC97AD1-FC72-456E-AC0B-CC4A24DBCB36Q53072737-0D6B344B-3A5A-4544-B04E-C6A9E3A1C403Q57109701-3FA99519-7BEC-409F-8813-C74250275B72
P2860
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@en
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@nl
type
label
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@en
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@nl
prefLabel
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@en
Matrix metalloproteinases 1 an ...... patients with prostate cancer.
@nl
P2093
P2860
P1476
Matrix metalloproteinases 1 an ...... patients with prostate cancer
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H
P50
P577
1997-04-01T00:00:00Z